Publications by authors named "Marlon D Cowart"

Claim this Profile
S
Synthesis and Pharmacology of (Pyridin-2-yl)methanol Derivatives as Novel and Selective Transient Receptor Potential Vanilloid 3 Antagonists.
Arthur Gomtsyan, Robert G Schmidt, Erol K Bayburt, Gregory A Gfesser, Eric A Voight, Marlon D Cowart

J Med Chem· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antagonism of supraspinal histamine H3 receptors modulates spinal neuronal activity in neuropathic rats.
Steve McGaraughty, Katharine L Chu, Marlon D Cowart, Jorge D Brioni

J Pharmacol Exp Ther· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacological properties and procognitive effects of ABT-288, a potent and selective histamine H3 receptor antagonist.
Timothy A Esbenshade, Kaitlin E Browman, Thomas R Miller, Kathleen M Krueger, Victoria Komater-Roderwald, Marlon D Cowart

J Pharmacol Exp Ther· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of histamine H3 antagonists for the treatment of cognitive disorders and Alzheimer's disease.
Jorge D Brioni, Tim A Esbenshade, Tiffany Runyan Garrison, Scott R Bitner, Marlon D Cowart

J Pharmacol Exp Ther· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diaryldiamines with dual inhibition of the histamine H(3) receptor and the norepinephrine transporter and the efficacy of 4-(3-(methylamino)-1-phenylpropyl)-6-(2-(pyrrolidin-1-yl)ethoxy)naphthalen-1-ol in pain.
Robert J Altenbach, Lawrence A Black, Marina I Strakhova, Arlene M Manelli, Tracy L Carr, Marlon D Cowart

J Med Chem· November 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antinociceptive effects of histamine H3 receptor antagonist in the preclinical models of pain in rats and the involvement of central noradrenergic systems.
Gin C Hsieh, Prisca Honore, Madhavi Pai, Erica J Wensink, Prasant Chandran, Marlon D Cowart

Brain Res· October 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vitro studies on a class of quinoline containing histamine H3 antagonists.
Huaqing Liu, Robert J Altenbach, Gilbert J Diaz, Arlene M Manelli, Ruth L Martin, Marlon D Cowart

Bioorg Med Chem Lett· June 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
H4 receptor antagonism exhibits anti-nociceptive effects in inflammatory and neuropathic pain models in rats.
Gin C Hsieh, Prasant Chandran, Anita K Salyers, Madhavi Pai, Chang Z Zhu, Marlon D Cowart

Pharmacol Biochem Behav· March 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design of a new histamine H3 receptor antagonist chemotype: (3aR,6aR)-5-alkyl-1-aryl-octahydropyrrolo[3,4-b]pyrroles, synthesis, and structure-activity relationships.
Chen Zhao, Minghua Sun, Youssef L Bennani, Thomas R Miller, David G Witte, Marlon D Cowart

J Med Chem· August 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
cis-4-(Piperazin-1-yl)-5,6,7a,8,9,10,11,11a-octahydrobenzofuro[2,3-h]quinazolin-2-amine (A-987306), a new histamine H4R antagonist that blocks pain responses against carrageenan-induced hyperalgesia.
Huaqing Liu, Robert J Altenbach, Tracy L Carr, Prasant Chandran, Gin C Hsieh, Marlon D Cowart

J Med Chem· November 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Structure-activity studies on a series of a 2-aminopyrimidine-containing histamine H4 receptor ligands.
Robert J Altenbach, Ronald M Adair, Brian M Bettencourt, Lawrence A Black, Shannon R Fix-Stenzel, Marlon D Cowart

J Med Chem· October 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rotationally constrained 2,4-diamino-5,6-disubstituted pyrimidines: a new class of histamine H4 receptor antagonists with improved druglikeness and in vivo efficacy in pain and inflammation models.
Marlon D Cowart, Robert J Altenbach, Huaqing Liu, Gin C Hsieh, Irene Drizin

J Med Chem· October 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The alkaloid conessine and analogues as potent histamine H3 receptor antagonists.
Chen Zhao, Minghua Sun, Youssef L Bennani, Sujatha M Gopalakrishnan, David G Witte, Marlon D Cowart

J Med Chem· September 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A robust and high-capacity [(35)S]GTPgammaS binding assay for determining antagonist and inverse agonist pharmacological parameters of histamine H(3) receptor ligands.
Thomas R Miller, John L Baranowski, Brian R Estvander, David G Witte, Tracy L Carr, Marlon D Cowart

Assay Drug Dev Technol· June 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vitro SAR of pyrrolidine-containing histamine H3 receptor antagonists: trends across multiple chemical series.
Diana L Nersesian, Lawrence A Black, Thomas R Miller, Timothy A Vortherms, Timothy A Esbenshade, Marlon D Cowart

Bioorg Med Chem Lett· January 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An 80-amino acid deletion in the third intracellular loop of a naturally occurring human histamine H3 isoform confers pharmacological differences and constitutive activity.
Gerold Bongers, Kathleen M Krueger, Thomas R Miller, John L Baranowski, Brian R Estvander, Marlon D Cowart

J Pharmacol Exp Ther· December 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis, potency, and in vivo profiles of quinoline containing histamine H3 receptor inverse agonists.
Robert J Altenbach, Huaqing Liu, Patricia N Banfor, Kaitlin E Browman, Gerard B Fox, Marlon D Cowart

J Med Chem· November 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of 3-methyl-N-(1-oxy-3',4',5',6'-tetrahydro-2'H-[2,4'-bipyridine]-1'-ylmethyl)benzamide (ABT-670), an orally bioavailable dopamine D4 agonist for the treatment of erectile dysfunction.
Meena V Patel, Teodozyj Kolasa, Kathleen Mortell, Mark A Matulenko, Ahmed A Hakeem, Marlon D Cowart

J Med Chem· December 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vitro preclinical cardiac assessment of tolterodine and terodiline: multiple factors predict the clinical experience.
Ruth L Martin, Zhi Su, James T Limberis, Jason D Palmatier, Marlon D Cowart

J Cardiovasc Pharmacol· November 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Crystal structures of human adenosine kinase inhibitor complexes reveal two distinct binding modes.
Steven W Muchmore, Richard A Smith, Andrew O Stewart, Marlon D Cowart, Arthur Gomtsyan

J Med Chem· November 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lack of efficacy of melanin-concentrating hormone-1 receptor antagonists in models of depression and anxiety.
Ana M Basso, Natalie A Bratcher, Kelly B Gallagher, Marlon D Cowart, Chen Zhao

Eur J Pharmacol· July 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Histamine H3 receptor antagonists: preclinical promise for treating obesity and cognitive disorders.
Timothy A Esbenshade, Gerard B Fox, Marlon D Cowart

Mol Interv· April 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
2
2-[4-(3,4-Dimethylphenyl)piperazin-1-ylmethyl]-1H benzoimidazole (A-381393), a selective dopamine D4 receptor antagonist.
Masaki Nakane, Marlon D Cowart, Gin C Hsieh, Loan Miller, Marie E Uchic

Neuropharmacology· July 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
5
5-(3-Bromophenyl)-7-(6-morpholin-4-ylpyridin-3-yl)pyrido[2,3-d]pyrimidin-4-ylamine: structure-activity relationships of 7-substituted heteroaryl analogs as non-nucleoside adenosine kinase inhibitors.
Mark A Matulenko, Chih-Hung Lee, Meiqun Jiang, Robin R Frey, Marlon D Cowart

Bioorg Med Chem· June 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Structure-activity relationships of arylbenzofuran H3 receptor antagonists.
Gregory A Gfesser, Ramin Faghih, Youssef L Bennani, Michael P Curtis, Timothy A Esbenshade, Marlon D Cowart

Bioorg Med Chem Lett· May 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis